Clinical Trial

Oral Iron in Children With Chronic Kidney Disease

Study acronym: FeTCh-CKD
Recruiting Phase 4
View on ClinicalTrials.gov →
Summary
This is a pilot clinical trial of oral iron therapy in children with chronic kidney disease (CKD) and mild anemia. Eligible children will be randomized into a standard of care (iron sulfate) arm vs. no iron therapy arm for 3 months. The outcomes will include muscle strength, physical activity, and changes in eating behavior, which will be measured at enrollment and at the end of the study period.
Protocol Amendment History 7 amendments
This ClinicalTrials.gov record has been amended 7 times since 2019-06-17; most recent amendment 2025-08-05.
Trial Details
NCT Number NCT03991169
Lead Sponsor Weill Medical College of Cornell University
Collaborators: Children's Hospital of Philadelphia
Conditions Chronic Kidney Insufficiency, Chronic Kidney Diseases
Enrollment 40 participants
Start Date 2019-04-19
Primary Completion 2028-12-31 (estimated)
Study Completion 2028-12-31 (estimated)
Updated on ClinicalTrials.gov 2025-08-11